Edwards, K. L., Irons, B. K., & Xu, T. (2006). Cost-effectiveness of intermediate or long-acting insulin versus Exenatide in type 2 diabetes mellitus patients not optimally controlled on dual oral diabetes medications. Centro de Investigaciones y Publicaciones Farmaceuticas.
Citação norma ChicagoEdwards, Krystal L., Brian K. Irons, e Tom Xu. Cost-effectiveness of Intermediate or Long-acting Insulin Versus Exenatide in Type 2 Diabetes Mellitus Patients Not Optimally Controlled On Dual Oral Diabetes Medications. Centro de Investigaciones y Publicaciones Farmaceuticas, 2006.
Citação norma MLAEdwards, Krystal L., Brian K. Irons, e Tom Xu. Cost-effectiveness of Intermediate or Long-acting Insulin Versus Exenatide in Type 2 Diabetes Mellitus Patients Not Optimally Controlled On Dual Oral Diabetes Medications. Centro de Investigaciones y Publicaciones Farmaceuticas, 2006.